Earnings · China A-shares
Hunan Fangsheng Pharmaceutical Co., Ltd. Class A (603998) earnings
Hunan Fangsheng Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +7.60% year on year, +24.27% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.86% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +7.60%
- Excl. one-offs YoY
- +24.27%
- Net profit QoQ
- -16.70%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -6.86% | — |
| 3 days | -4.86% | — |
| 7 days | -1.81% | — |
| 14 days | +1.48% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +0.96%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥288.68M | +7.60% | +24.27% | +10.44% | 0.66 | 16.33% | -4.86% | — | — |
| 2026 interim report | 2026-08-29 | ¥197.66M | +16.79% | +23.07% | +14.80% | 0.45 | 11.33% | +6.10% | +0.08% | +9.41% |
| 2026 Q1 report | 2026-04-25 | ¥88.39M | +0.15% | +21.19% | +10.69% | 0.20 | 5.16% | +4.08% | -8.82% | -8.51% |
| 2025 annual report | 2026-04-25 | ¥306.39M | +20.05% | +28.69% | -1.75% | 0.70 | 18.23% | +4.08% | -8.82% | -8.51% |
| 2025 Q3 report | 2025-10-24 | ¥268.28M | +17.60% | +30.54% | -7.02% | 0.61 | 15.71% | +2.95% | -6.38% | -6.16% |
| 2025 interim report | 2025-08-29 | ¥169.24M | +23.67% | +27.79% | -8.35% | 0.39 | 10.01% | -1.62% | +3.83% | +2.56% |
| 2025 Q1 report | 2025-04-29 | ¥88.26M | +25.74% | +31.41% | -4.62% | 0.20 | 5.32% | -0.91% | +7.78% | +5.20% |
| 2024 annual report | 2025-04-29 | ¥255.22M | +36.61% | +44.61% | +9.15% | 0.59 | 16.60% | -0.91% | +7.78% | +5.20% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.